NEU neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-76

  1. 998 Posts.
    lightbulb Created with Sketch. 174
    Further to Hottod's post in the china thread re: Patent for crystalline form of Trofinetide, the below noted patents and the diseases they list as covering are quite mind blowing.
    https://patentscope.wipo.int/search/en/detail.jsf?docId=US390987568&_cid=P20-LE6B2F-95444-1
    https://hotcopper.com.au/data/attachments/5057/5057869-97612e3eaec38db6bd7d7e9af5143f7a.jpg

    @hottod, thanks for providing links to this too and in doing some further searches thought these patents for NNZ-2591 might be of great interest
    https://patentscope.wipo.int/search/en/result.jsf?_vid=P20-LE6EIT-25991
    [if this link doesnt work just type in search bar Neuren Pharmaceuticals and it'll throw up all their patents e.g.]
    https://patentscope.wipo.int/search/en/detail.jsf?docId=US217775640&_cid=P20-LE6EJL-26232-1
    https://patentscope.wipo.int/search/en/detail.jsf?docId=US191715060&_cid=P20-LE6EJL-26232-1

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.